Misplaced Pages

3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from 3-alpha-hydroxyacyl-CoA dehydrogenase deficiency) Medical condition
3-hydroxyacyl-coenzyme A dehydrogenase deficiency
Other namesHADH deficiency

3-hydroxyacyl-coenzyme A dehydrogenase deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during fasting. Normally, through a process called fatty acid oxidation, several enzymes work in a step-wise fashion to metabolize fats and convert them to energy. People with 3-hydroxyacyl-coenzyme A dehydrogenase deficiency have inadequate levels of an enzyme required for a step that metabolizes groups of fats called medium chain fatty acids and short chain fatty acids; for this reason this disorder is sometimes called medium- and short-chain 3-hydroxyacyl-coenzyme A dehydrogenase (M/SCHAD) deficiency.

Signs and symptoms

Typically, initial signs and symptoms of this disorder occur during infancy or early childhood and can include poor appetite, vomiting, diarrhea, lethargy, hypoglycemia, hypotonia, liver problems, and hyperinsulinism (high levels of insulin). Insulin controls the amount of sugar that moves from the blood into cells for conversion to energy. Individuals with 3-hydroxyacyl-coenzyme A dehydrogenase deficiency are also at risk for complications such as seizures, life-threatening heart and breathing problems, coma, and sudden unexpected death.

Problems related to 3-hydroxyacyl-coenzyme A dehydrogenase deficiency can be triggered by periods of fasting or by illnesses such as viral infections. This disorder is sometimes mistaken for Reye syndrome, a severe disorder that may develop in children while they appear to be recovering from viral infections such as chicken pox or flu. Most cases of Reye syndrome are associated with the use of aspirin during these viral infections.

Genetics

Mutations in the HADH gene lead to inadequate levels of an enzyme called 3-hydroxyacyl-coenzyme A dehydrogenase. Medium-chain and short-chain fatty acids cannot be metabolized and processed properly without sufficient levels of this enzyme. As a result, these fatty acids are not converted to energy, which can lead to characteristic features of this disorder, such as lethargy and hypoglycemia. Medium-chain and short-chain fatty acids or partially metabolized fatty acids may build up in tissues and damage the liver, heart, and muscles, causing more serious complications.

This condition is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Most often, the parents of an individual with an autosomal recessive disorder each carry one copy of the altered gene but do not show signs and symptoms of the disorder.

Diagnosis

This section is empty. You can help by adding to it. (February 2017)

Treatment

This section is empty. You can help by adding to it. (February 2017)

See also

References

  1. Reference, Genetics Home. "3-hydroxyacyl-CoA dehydrogenase deficiency". Genetics Home Reference. Retrieved 2017-02-27.

External links

ClassificationD
Inborn error of lipid metabolism: fatty-acid metabolism disorders
Synthesis
Degradation
Acyl
transport
Beta
oxidation
General
Unsaturated
Odd chain
Other
To
acetyl-CoA
Aldehyde
Medicine
Specialties
and
subspecialties
Surgery
Internal
medicine
Obstetrics and
gynaecology
Diagnostic
Other
Medical
education
Related topics
Category: